Undervalued Small-Cap Healthcare Stocks on TSE October 2024

October 30, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
VPH Valeo Pharma 0.04 0.12 162.89 20960 4 0.00 0.0
AVNT Avant Brands 0.88 2.25 155.92 9341 9 0.00 0.0
QIPT Quipt Home Medical 3.78 7.40 95.87 22569 161 0.00 0.0
RVX Resverlogix 0.07 0.12 89.77 66300 18 0.00 0.0
CSCI Cosciens Biopharma 5.04 8.19 62.59 1137 11 0.00 0.0
CWEB Charlottes Web Holdings 0.21 0.34 60.00 36756 33 0.00 0.0
CRRX CareRx 1.99 2.98 49.65 11837 120 0.00 0.0
AIDX Healwell AI 1.23 1.83 48.75 310831 154 0.00 0.0
APLI Appili Therapeutics 0.04 0.05 44.69 103459 4 0.00 0.0
CRON Cronos Group 3.08 4.40 42.71 83462 1177 0.00 0.0
All data provided as at market close October 28, 2024.

Company Details

Valeo Pharma

VPH:TSX

Close Price

0.04

Our Valuation

0.12

% Difference

162.89

Market Cap ($M)

4

P/E Ratio

0.0

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Access the stockcalc valuation


Avant Brands

AVNT:TSX

Close Price

0.88

Our Valuation

2.25

% Difference

155.92

Market Cap ($M)

9

P/E Ratio

0.0

Avant Brands Inc is an innovative premium cannabis company. It has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for highly desired, and award-winning consumer brands, sold across both recreational and medical channels. The company's diverse product range is distributed through three distinct sales channels: recreational, medical, and export.

Access the stockcalc valuation


Quipt Home Medical

QIPT:TSX

Close Price

3.78

Our Valuation

7.40

% Difference

95.87

Market Cap ($M)

161

P/E Ratio

0.0

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.

Access the stockcalc valuation


Resverlogix

RVX:TSX

Close Price

0.07

Our Valuation

0.12

% Difference

89.77

Market Cap ($M)

18

P/E Ratio

0.0

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Cosciens Biopharma

CSCI:TSX

Close Price

5.04

Our Valuation

8.19

% Difference

62.59

Market Cap ($M)

11

P/E Ratio

0.0

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.

Access the stockcalc valuation


Charlottes Web Holdings

CWEB:TSX

Close Price

0.21

Our Valuation

0.34

% Difference

60.00

Market Cap ($M)

33

P/E Ratio

0.0

Charlottes Web Holdings Inc is engaged in the production and distribution of hemp-based cannabidiol (CBD) wellness products. Its product categories include ingestible products (tinctures, capsules, and gummies), topicals, and pet products. The company distributes its products through an e-commerce website, third-party e-commerce websites, select distributors, health practitioners, and a variety of brick-and-mortar specialty retailers.

Access the stockcalc valuation


CareRx

CRRX:TSX

Close Price

1.99

Our Valuation

2.98

% Difference

49.65

Market Cap ($M)

120

P/E Ratio

0.0

CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.

Access the stockcalc valuation


Healwell AI

AIDX:TSX

Close Price

1.23

Our Valuation

1.83

% Difference

48.75

Market Cap ($M)

154

P/E Ratio

0.0

Healwell AI Inc is a healthcare technology company focused on AI and data science for preventative care. The company operates primary care networks and pioneering how actionable insights from data can be paired with targeted therapeutics to start treating disease before it's too late. Its technologies are backed by science and powered by AI.

Access the stockcalc valuation


Appili Therapeutics

APLI:TSX

Close Price

0.04

Our Valuation

0.05

% Difference

44.69

Market Cap ($M)

4

P/E Ratio

0.0

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.

Access the stockcalc valuation


Cronos Group

CRON:TSX

Close Price

3.08

Our Valuation

4.40

% Difference

42.71

Market Cap ($M)

1177

P/E Ratio

0.0

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Valeo Pharma and Avant Brands are the most undervalued Small-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-october-2024
Valeo Pharma $VPH and Avant Brands $AVNT are the most undervalued Healthcare stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-october-2024
Valeo Pharma and Avant Brands are the most undervalued Small-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-october-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.